Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/PFIZ34 stock hub

BVMF/PFIZ34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/PFIZ34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

716.8B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/PFIZ34

In the news

Latest news · BVMF/PFIZ34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.9

P25 11.3P50 14.6P75 19.6

Trailing P/E18.3

P25 15.2P50 21.5P75 27.3

ROE8.3

P25 5.3P50 12.3P75 22.5

ROIC12.7

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/PFIZ34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	75,000
Employees Change	-6,000%
Employees Change Percent	-7.41
Enterprise value	BRL 971.3B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	BRPFIZBDR006
Last refreshed	2026-05-10
Market cap	BRL 716.8B
Price	BRL 31.56
Price currency	BRL
Rev Per Employee	4,424,426.87x
Sector	Healthcare
Sic	2834
Symbol	bvmf/PFIZ34
Website	https://www.pfizer.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.48%
EV Earnings	24.74x
EV/EBIT	10.49x
EV/EBITDA	7.52x
EV/FCF	19.54x
EV/Sales	3.13x
FCF yield	6.93%
Forward P/E	8.86x
P/B ratio	1.51x
P/E ratio	18.26x
P/S ratio	2.16x
PE Ratio10 Y	18.93x
PE Ratio3 Y	24.51x
PE Ratio5 Y	18.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.87%
EBITDA Margin	40.21%
FCF margin	14.98%
Gross margin	74.8%
Gross Profit	BRL 248.2B
Gross Profit Growth	3.59%
Gross Profit Growth Q	-0.71%
Gross Profit Growth3 Y	-9.68%
Gross Profit Growth5 Y	5.93%
Net Income	BRL 39.3B
Net Income Growth	-4.97%
Net Income Growth Q	-9.44%
Net Income Growth3 Y	-36.35%
Net Income Growth5 Y	-6.85%
Pretax Margin	12.49%
Profit Margin	11.83%
Profit Per Employee	BRL 523,468
ROA	5.69
Roa5y	7.03
ROCE	10.91
ROE	8.31
Roe5y	17.68
ROIC	12.72
Roic5y	18.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.16%
Cagr1y	2.33%
Cagr3y	-8.71%
Cagr5y	-6.27%
Div CAGR10	3.46%
Div CAGR3	2.75%
Div CAGR5	-55%
EPS Growth	-5.1
EPS Growth Q	-10.05
EPS Growth3 Y	-36.28
EPS Growth5 Y	-7.08
FCF Growth	-15.48%
FCF Growth Q	23.04%
FCF Growth3 Y	-22.29%
FCF Growth5 Y	-6.79%
OCF Growth	-14.33%
OCF Growth Q	11.99%
OCF Growth10 Y	-2.74%
OCF Growth3 Y	-20.6%
OCF Growth5 Y	-5.39%
Revenue Growth	1.36x
Revenue Growth Q	5.37x
Revenue Growth3 Y	-12.08x
Revenue Growth5 Y	6.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.3
Assets	BRL 1.1T
Cash	BRL 68.6B
Current Assets	BRL 210.4B
Current Liabilities	BRL 168.8B
Debt	BRL 339.3B
Debt EBITDA	BRL 2.45
Debt Equity	BRL 0.72
Debt FCF	BRL 6.83
Equity	BRL 473.8B
Interest Coverage	7.04
Liabilities	BRL 614.3B
Long Term Assets	BRL 877.7B
Long Term Liabilities	BRL 445.5B
Net Cash	BRL -270.7B
Net Cash By Market Cap	BRL -37.76
Net Debt EBITDA	BRL 2.03
Net Debt Equity	BRL 0.57
Net Debt FCF	BRL 5.45
Tangible Book Value	BRL -177.5B
Tangible Book Value Per Share	BRL -31.15
WACC	5.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.25
Inventory Turnover	1.48
Net Working Capital	BRL -3.8B
Quick ratio	0.85
Working Capital	BRL 44.4B
Working Capital Turnover	BRL 37.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.26%
Dividend Growth	-7.76%
Dividend Growth Years	2%
Dividend per share	BRL 1.53
Dividend Years	17
Dividend Yield	4.83%
Ex Div Date	2026-05-07
Last Dividend	BRL 0.36
Payout Frequency	Quarterly
Payout Ratio	130.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	50.27%
1Y total return	2.33%
200-day SMA	34.07
3Y total return	-23.93%
50-day SMA	34.56
50-day SMA vs 200-day SMA	50over200
5Y total return	-27.64%
All Time High	88.24
All Time High Change	-64.23%
All Time High Date	2021-12-20
All Time Low	8.65
All Time Low Change	264.86%
All Time Low Date	2011-05-18
ATR	0.83
Beta	0.31
Ch YTD	-8.52
High	32.32
High52	37.07
High52 Date	2026-04-02
High52ch	-14.86%
Low	31.46
Low52	30.84
Low52 Date	2025-05-12
Low52ch	2.34%
Ma50ch	-8.67%
Price vs 200-day SMA	-7.36%
RSI	30.22
RSI Monthly	36.61
RSI Weekly	37.75
Sharpe ratio	0.08x
Sortino ratio	0.34
Total Return	4.57%
Tr YTD	-6.46
Tr1m	-8.48%
Tr1w	-2.31%
Tr3m	-9.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 99.1B
Operating Income Growth	20.65
Operating Income Growth Q	-5.27
Operating Income Growth3 Y	-18.95
Operating Income Growth5 Y	10.43
Operating margin	29.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,691,728,668%
Net Borrowing	10,973,408,600
Shares Insiders	0.03%
Shares Institutions	67.59%
Shares Qo Q	0.79%
Shares Yo Y	0.26%
Short Ratio	3.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 45B
Average Volume	7,557.1x
Bv Per Share	82.86
CAPEX	BRL -13.1B
Ch10y	7
Ch1m	-9.49
Ch1w	-3.4
Ch1y	-3.43
Ch3m	-10.14
Ch3y	-33.49
Ch5y	-39.18
Ch6m	-2.5
Change	-1.41%
Change From Open	-2.35
Close	32.01
Days Gap	0.97
Depreciation Amortization	32,188,010,000
Dollar Volume	283,566.6
Earnings Date	2026-05-05
EBIT	BRL 99.1B
EBITDA	BRL 133.4B
EPS	BRL 6.88
F Score	6
FCF	BRL 49.7B
FCF EV Yield	5.12x
Financing CF	-41,576,615,010
Fiscal Year End	December
Founded	1,849
Goodwill	350,918,107,800
Graham Number	28.48346
Graham Upside	-9.75
Income Tax	BRL 2B
Investing CF	-20,125,324,800
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-29
Last Split Date	2020-10-29
Last Split Type	Forward
Lynch Fair Value	BRL 8.64
Lynch Upside	-72.62
Ma150	34.32
Ma150ch	-8.03%
Ma20	33.32
Ma20ch	-5.27%
Net CF	1,462,230,630
Next Earnings Date	2026-07-28
Open	32.32
P FCF Ratio	14.42
P OCF Ratio	11.41
Payment Date	2026-06-18
Position In Range	11.63
Ppne	95,345,308,400
Price Date	2026-05-08
Price EBITDA	BRL 5.37
Relative Volume	1.21x
Revenue	331,832,015,550x
SBC By Revenue	1.42x
Share Based Comp	4,722,113,970
Tax By Revenue	0.61x
Tax Rate	4.86%
Tr6m	-0.31%
Volume	8,985
Z Score	2.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/PFIZ34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.8%

$1.53 annual per share

Payout ratio

+130.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-55.0%

2 consecutive years of growth

Total shareholder yield

+4.6%

Next ex-dividend date: 2026-05-07

Performance

BVMF/PFIZ34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/PFIZ34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+67.6%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/PFIZ34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.2

Neutral momentum band

Price vs 200-day MA

-7.4%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/PFIZ34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/PFIZ34 stock rating?

bvmf/PFIZ34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/PFIZ34 analysis?

The full report lives at /stocks/bvmf/PFIZ34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/PFIZ34?

The latest report frames bvmf/PFIZ34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/PFIZ34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.